Publications
Sevelamer Use in End-Stage Kidney Disease (ESKD) Patients Associates with Poor Vitamin K Status and High Levels of Gut-Derived Uremic Toxins: A Drug-Bug Interaction? KU Leuven
Drug interactions Ghent University
Prevalence and management of drug interactions between nonsteroidal anti-inflammatory drugs and antithrombotics in ambulatory care Ghent University
Identification of drugs acting as perpetrators in common drug interactions in a cohort of geriatric patients from Southern Italy and analysis of the gene polymorphisms that affect their interacting potential Ghent University
Mini-series: II. Clinical aspects. Clinically relevant CYP450-mediated drug interactions in the ICU KU Leuven
Influence of Drug Transport Proteins on the Pharmacokinetics and Drug Interactions of HIV Protease Inhibitors KU Leuven
Pharmacokinetic Interactions between the Hepatitis C Virus Inhibitors Elbasvir and Grazoprevir and HIV Protease Inhibitors Ritonavir, Atazanavir, Lopinavir, and Darunavir in Healthy Volunteers KU Leuven
Prevalence of alcohol-drug interactions in community-dwelling older patients with polypharmacy Vrije Universiteit Brussel
OBJECTIVES: Alcohol and medication use are increasingly prevalent in the older population. Concurrent use of alcohol and alcohol-interactive (AI) medication can lead to significant adverse consequences.
METHODS: Three reference works were used to create an explicit list of drug substances for which information about the interaction with alcohol was available in at least one of them. Additional information was extracted from the ...
Management of drug-disease interactions Vrije Universiteit Brussel
Background Drug-disease interactions are situations where pharmacotherapy may have a negative effect on patients' comorbidities. In these cases, it can be necessary to avoid that drug, adjust its dose or monitor therapy. In the Netherlands, pharmacists have developed a best practice how to systematically evaluate drug-disease interactions based on pharmacological considerations and implement recommendations for specific drug-disease ...